Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

61.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

25.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.4K
5.4K
pre-mRNA Processing02:01

pre-mRNA Processing

57.9K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.9K
Pre-mRNA Processing: Modification of pre-mRNA Ends01:35

Pre-mRNA Processing: Modification of pre-mRNA Ends

16.3K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
16.3K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

7.3K
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging role of G-quadruplexes in alternative splicing regulation.

Trends in genetics : TIG·2026
Same author

New proteomic signature in circulating extracellular vesicles from tumor-draining and peripheral veins of patients with lung adenocarcinoma.

Cancer cell international·2026
Same author

Cohesin and its regulation promote monopolar kinetochore orientation at meiosis I in Arabidopsis.

Current biology : CB·2026
Same author

Percutaneous Image-Guided Screw Fixation Combined with Cementoplasty for Radiation-Induced Pelvic Insufficiency Fractures: Feasibility, Safety, and Early Outcomes in a Multicenter Retrospective Study.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells.

Biosensors·2026
Same author

De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders.

Nature communications·2026

Related Experiment Video

Updated: Mar 9, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.6K

[Pre-mRNA splicing: when the spliceosome loses ground].

Gwendal Dujardin1, Élisabeth Daguenet1, Delphine G Bernard2

  • 1Centre de Regulació Genòmica (CRG), the Barcelona Institute of Science and Technology, Barcelone, Espagne.

Medecine Sciences : M/S
|January 4, 2017
PubMed
Summary

Alternative pre-mRNA splicing generates protein diversity but aberrant events cause diseases. This review covers regulated splicing, the spliceosome, and its defects in pathologies.

More Related Videos

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.6K
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

3.3K
A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.5K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Pre-messenger RNA (pre-mRNA) splicing is essential for mRNA maturation in eukaryotes.
  • Alternative splicing significantly expands protein diversity from a limited gene set.
  • Aberrant splicing is linked to diseases like cancer and neurodegeneration.

Purpose of the Study:

  • To review regulated alternative pre-mRNA splicing.
  • To present the spliceosome's role and structure.
  • To discuss spliceosome defects in disease.

Main Methods:

  • Literature review of splicing mechanisms and spliceosome function.
  • Analysis of spliceosome mutations in human diseases.
  • Discussion of cis and trans alterations affecting splicing.

Main Results:

  • Alternative splicing increases proteome complexity.
  • The spliceosome is a key regulator of splicing.
  • Spliceosome mutations are implicated in various pathologies.

Conclusions:

  • Regulated alternative splicing is crucial for cellular function and protein diversity.
  • Spliceosome dysfunction contributes to disease development.
  • Understanding splicing defects offers therapeutic targets.